The Micro-Immunotherapy Medicine 2LPAPI<sup>®</sup> Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells

The Micro-Immunotherapy Medicine 2LPAPI<sup>®</sup> Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells

Human papillomavirus (HPV) is the second most common infectious agent causing cancer. Persistent infection with high-risk (HR)-HPV can lead to cervical intra-epithelial neoplasia and cervical carcinomas (CC). While host immune response is necessary for viral clearance, chronic immune activation cont...

Full description

Bibliographic Details
Main Authors: Camille Jacques, Flora Marchand, Mathias Chatelais, Virginie Albinet, Claire Coustal, Ilaria Floris
Format: Article
Language:English
Published: MDPI AG 2024-04-01
Series:Cancers
Subjects:
micro-immunotherapy
cytokines
papillomavirus
cervical cancer
HeLa
immune response
Online Access:https://www.mdpi.com/2072-6694/16/7/1421

Internet

https://www.mdpi.com/2072-6694/16/7/1421

Similar Items